FindTrial
Sign In

Study of the effects of manual lymphatic drainage in water and electrolytic mobilization and heart rate alteration in women in the reproductive and climacteric phases compared to the same parameters in men

Study of the efficacy of manual lymphatic drainage in hidroelectrolytic mobilization and heart rate variability in women in the reproductive and climacteric phases compared to the same parameters in men

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-45c8br
Enrollment
Unknown
Registered
2016-12-19
Start date
2014-03-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

women who are in the climacteric

Interventions

Groups and procedures: GI: Number of participants = 15 with women who do not use contraceptives: Control day: Saliva collections, Record of Variability of Heart Rate and collection of urine at 8:00 h
9:00 a.m.
10:00 am
11:00 and noon. Day Lymphatic Drainage Manual: Saliva collections, record of heart rate variability and urine collection at 8:00 hours
11:00 and noon. At 9 o clock, after collection, manual lymphatic drainage will be applied as described: Manual Lymphatic Drainage (MLD): The Leduc method will be used
Leduc (2000) in lower limbs and abdomen for 50 min. It begins with 10 pumping maneuvers in the corresponding lymph nodes of each region and 10 drainage maneuvers in each point, starting in the proxima
Other
E02.190.599.750.750
A15.382.520.301
A12.207.927
E01.370.600.875.500

Sponsors

Instituto de Biologia Unicamp
Lead Sponsor
Universidade Metodista de Piracicaba
Collaborator

Eligibility

Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: ormotensos; Eutrophic (normal weight); Not having cardiovascular or respiratory system anomalies; Of endocrine diseases; Non-smoking and non-alcoholic; For perimenopause population may be included voluntary overweight; Self-declared healthy; For the young age group of 18-30 years; Perimenopause age range of 40-50 years.

Exclusion criteria

Exclusion criteria: Presence of acute infections and inflammations; phlebitis; thromboses or thrombophlebitis; hyperthyroidism; cardiopathies; chronic renal diseases; metaplasias and immune disorders; hypersensitivity of the carotid sinus; Use of diuretic medications; antidepressants; anxiolytics or any other medicinal treatments.

Design outcomes

Primary

MeasureTime frame
Increased elimination of electrolytes, glycerol and atrial natriuretic factor in the urine verified by measurement of these components in the urine.;Change in heart rate verified by recording and analysis of heart rate variability.;Alteration in the rhythmicity of cortisol production verified by the quantification of salivary cortisol.—

Secondary

MeasureTime frame
Secondary outcomes are not expected—

Countries

Brazil

Contacts

Public ContactDora Grassi-Kassisse

Instituto de Biologia Unicamp

doramgk@unicamp.br+55 19 35216186

Outcome results

None listed

Source: REBEC (via WHO ICTRP)